Occludin Is Essential to Maintain Normal Alveolar Barrier Integrity and Its Protective Role During ARDS Progression

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Pathophysiology

Background:

• Acute respiratory distress syndrome (ARDS) is a severe lung injury with compromised epithelial and endothelial barriers.
• The role of the tight junction protein occludin in ARDS pathogenesis is not well understood.
• Occludin has been considered redundant in some tissues, necessitating investigation into its lung-specific function.

Purpose of the Study:

• To investigate the role of occludin in maintaining alveolar barrier integrity in the context of ARDS.
• To determine if occludin expression levels correlate with lung injury severity.
• To explore the therapeutic potential of targeting occludin for ARDS treatment.

Main Methods:

• Immunofluorescence staining of lung tissue from ARDS patients and controls.
• Gene delivery of shRNA targeting occludin in mouse lungs to assess injury.
• Gene delivery of an occludin-expressing plasmid to evaluate protective effects.
• In vitro studies using primary rat alveolar epithelial cells to assess barrier function.

Main Results:

• ARDS patient lungs showed significantly decreased occludin expression compared to controls.
• Reduced occludin levels in mice led to increased lung injury markers (wet-to-dry ratio, histology, BAL fluid analysis).
• Increased occludin expression in mice attenuated endotoxin-induced lung injury.
• Occludin levels in rat alveolar cells correlated positively with barrier integrity and claudin-18 localization.

Conclusions:

• Occludin is essential for maintaining alveolar barrier function in the lung.
• Decreased occludin expression contributes to the pathogenesis of acute respiratory distress syndrome.
• Modulating occludin levels presents a potential novel therapeutic strategy for ARDS.